MyCap in Action: Use of MyCap in the PREP Study and Additional Use Cases

Discover how Texas A&M and Phillips North leveraged the MyCap Mobile App in the Persistent Readiness Through Early Prediction (PREP) study. To assess vaccine-mediated immune responses in healthy adults after receiving the Typhim Vi and PPSV23 vaccines, 210 individuals were tasked with completing daily questionnaires via MyCap, uploading facial photographs, and recording scripted audio clips for staff review in this study. Following the study team’s presentation of their use case, the MyCap team will also share updates on new app features, app growth milestones, and insights into other published use cases.

This event, hosted by the Trial Innovation Network, is made available to the University of Rochester community via the University of Rochester Medicine Clinical and Translational Science Institute.